Invex Therapeutics Dividends and Buybacks
Dividend criteria checks 2/6
Invex Therapeutics is a dividend paying company with a current yield of 207%.
Key information
207.0%
Dividend yield
207.0%
Buyback Yield
| Total Shareholder Yield | 207.0% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely
Jun 09
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely
Jan 11We Think Invex Therapeutics (ASX:IXC) Can Afford To Drive Business Growth
Aug 24Companies Like Invex Therapeutics (ASX:IXC) Are In A Position To Invest In Growth
May 10Companies Like Invex Therapeutics (ASX:IXC) Can Afford To Invest In Growth
Jan 25We're Interested To See How Invex Therapeutics (ASX:IXC) Uses Its Cash Hoard To Grow
Sep 27We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely
Mar 31Should You Review Recent Insider Transactions At Invex Therapeutics Ltd (ASX:IXC)?
Feb 06We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely
Dec 15
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if IXC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IXC's dividend payments have been increasing.
Dividend Yield vs Market
| Invex Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (IXC) | 207.0% |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.2% |
| Industry Average (Pharmaceuticals) | 2.3% |
| Analyst forecast (IXC) (up to 3 years) | n/a |
Notable Dividend: IXC's dividend (207%) is higher than the bottom 25% of dividend payers in the Australian market (2.63%).
High Dividend: IXC's dividend (207%) is in the top 25% of dividend payers in the Australian market (6.11%)
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate IXC's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as IXC has not reported any payouts.